Juvenile dermatomyositis in Thai children

S Singalavanija1, S Liamsuwan, W Limpongsanurak

  • 1Dermatology Unit, Queen Sirikit National Institute of Child Health, Bangkok, Thailand.

Insights

Juvenile dermatomyositis (JDM) is a rare autoimmune disease causing muscle weakness and skin rash in children. Early diagnosis and treatment are crucial to prevent long-term disability, although calcinosis cutis can be a persistent complication.

Area of Science:

  • Pediatrics
  • Rheumatology
  • Dermatology

Background:

  • Juvenile dermatomyositis (JDM) is a rare, chronic, multisystemic inflammatory disorder of unknown cause.
  • It is characterized by a distinct skin rash and proximal muscle weakness in children.

Purpose of the Study:

  • To retrospectively analyze cases of juvenile dermatomyositis diagnosed at a specific institute.
  • To understand the clinical presentation, diagnostic findings, treatment outcomes, and long-term complications.

Main Methods:

  • Retrospective review of medical records of patients diagnosed with JDM between 1988 and 1998.
  • Analysis of presenting symptoms, cutaneous manifestations, diagnostic tests (EMG, muscle biopsy), and treatment responses.
  • Evaluation of long-term outcomes, including calcinosis cutis.

Main Results:

  • Seven cases of JDM were identified, with a female predominance (6:1) and a mean age of diagnosis of 7 years.
  • Common symptoms included proximal muscle weakness and characteristic skin rashes like heliotrope signs and Gottron's papules.
  • Electromyography and muscle biopsy confirmed myositis; oral prednisolone improved muscle weakness in most cases, with no mortality observed.
  • Four patients developed calcinosis cutis, a complication that appeared 1-3 years after muscle weakness onset and was unresponsive to treatment.

Conclusions:

  • Juvenile dermatomyositis can lead to chronic disability in children.
  • Early diagnosis and prompt treatment are essential for preventing significant morbidity and mortality.
  • Calcinosis cutis is a common, treatment-resistant complication that often manifests years after the initial presentation of muscle weakness.

Related Concept Videos

Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...